Fox transcription factors: from development to disease

ML Golson, KH Kaestner - Development, 2016 - journals.biologists.com
Forkhead box (Fox) transcription factors are evolutionarily conserved in organisms ranging
from yeast to humans. They regulate diverse biological processes both during development …

Virus-like nanoparticles as a theranostic platform for cancer

KR Kim, AS Lee, SM Kim, HR Heo… - … in Bioengineering and …, 2023 - frontiersin.org
Virus-like nanoparticles (VLPs) are natural polymer-based nanomaterials that mimic viral
structures through the hierarchical assembly of viral coat proteins, while lacking viral …

Comprehensive identification of mutational cancer driver genes across 12 tumor types

D Tamborero, A Gonzalez-Perez, C Perez-Llamas… - Scientific reports, 2013 - nature.com
With the ability to fully sequence tumor genomes/exomes, the quest for cancer driver genes
can now be undertaken in an unbiased manner. However, obtaining a complete catalog of …

Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer

S Zhou, JR Hawley, F Soares, G Grillo, M Teng… - Nature …, 2020 - nature.com
Prostate cancer is the second most commonly diagnosed malignancy among men
worldwide. Recurrently mutated in primary and metastatic prostate tumors, FOXA1 encodes …

Androgen receptor-independent function of FoxA1 in prostate cancer metastasis

HJ Jin, JC Zhao, I Ogden, RC Bergan, J Yu - Cancer research, 2013 - AACR
Abstract FoxA1 (FOXA1) is a pioneering transcription factor of the androgen receptor (AR)
that is indispensible for the lineage-specific gene expression of the prostate. To date, there …

Delivery of siRNA therapeutics using cowpea chlorotic mottle virus-like particles

P Lam, NF Steinmetz - Biomaterials science, 2019 - pubs.rsc.org
While highly promising in medicine, gene therapy requires delivery agents to protect and
target nucleic acid therapeutics. We developed a plant viral siRNA delivery platform making …

Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification

JR Schoenborn, P Nelson, M Fang - Clinical Cancer Research, 2013 - AACR
The remarkable variation in prostate cancer clinical behavior represents an opportunity to
identify and understand molecular features that can be used to stratify patients into clinical …

GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas

DG Davis, MT Siddiqui, G Oprea-Ilies, K Stevens… - Human pathology, 2016 - Elsevier
GATA-3, a member of the GATA family of zinc-finger DNA binding proteins, and FOXA1, a
member of the forkhead transcription factor family, are both associated with estrogen …

Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma

M Maimaiti, S Sakamoto, Y Yamada, M Sugiura, J Rii… - Scientific reports, 2020 - nature.com
L-type amino acid transporter 1 (LAT1) plays a role in transporting essential amino acids
including leucine, which regulates the mTOR signaling pathway. Here, we studied the …

Up-regulation of LAT1 during antiandrogen therapy contributes to progression in prostate cancer cells

M Xu, S Sakamoto, J Matsushima, T Kimura… - The Journal of …, 2016 - auajournals.org
Purpose: Cancer cells require massive amounts of amino acids for survival. LAT1 (L-type
amino acid transporter 1) transports essential amino acids, including leucine, which trigger …